These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 27698849)

  • 1. Fluorescence
    Uguen A; Uguen M; Talagas M; Gobin E; Marcorelles P; De Braekeleer M
    Oncol Lett; 2016 Oct; 12(4):2734-2741. PubMed ID: 27698849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The p16-Ki-67-HMB45 Immunohistochemistry Scoring System is Highly Concordant With the Fluorescent In Situ Hybridization Test to Differentiate Between Melanocytic Nevi and Melanomas.
    Uguen A; Uguen M; Guibourg B; Talagas M; Marcorelles P; De Braekeleer M
    Appl Immunohistochem Mol Morphol; 2018 Jul; 26(6):361-367. PubMed ID: 27490764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation between Spitz nevi and malignant melanomas by interphase fluorescence in situ hybridization.
    Wettengel GV; Draeger J; Kiesewetter F; Schell H; Neubauer S; Gebhart E
    Int J Oncol; 1999 Jun; 14(6):1177-83. PubMed ID: 10339676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Diagnostic Algorithm Combining Immunohistochemistry and Molecular Cytogenetics to Diagnose Challenging Melanocytic Tumors.
    Redon S; Guibourg B; Talagas M; Marcorelles P; Uguen A
    Appl Immunohistochem Mol Morphol; 2018; 26(10):714-720. PubMed ID: 28362709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorescence in situ hybridization (FISH) analysis of melanocytic nevi and melanomas: sensitivity, specificity, and lack of association with sentinel node status.
    Fang Y; Dusza S; Jhanwar S; Busam KJ
    Int J Surg Pathol; 2012 Oct; 20(5):434-40. PubMed ID: 22561674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced detection of spitzoid melanomas using fluorescence in situ hybridization with 9p21 as an adjunctive probe.
    Gammon B; Beilfuss B; Guitart J; Gerami P
    Am J Surg Pathol; 2012 Jan; 36(1):81-8. PubMed ID: 21989344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorescence in situ hybridization for distinguishing nevoid melanomas from mitotically active nevi.
    Gerami P; Wass A; Mafee M; Fang Y; Pulitzer MP; Busam KJ
    Am J Surg Pathol; 2009 Dec; 33(12):1783-8. PubMed ID: 19809275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinction of conjunctival melanocytic nevi from melanomas by fluorescence in situ hybridization.
    Busam KJ; Fang Y; Jhanwar SC; Pulitzer MP; Marr B; Abramson DH
    J Cutan Pathol; 2010 Feb; 37(2):196-203. PubMed ID: 20100177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorescence in situ hybridization as an ancillary tool in the diagnosis of ambiguous melanocytic neoplasms: a review of 804 cases.
    North JP; Garrido MC; Kolaitis NA; LeBoit PE; McCalmont TH; Bastian BC
    Am J Surg Pathol; 2014 Jun; 38(6):824-31. PubMed ID: 24618603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A highly specific and discriminatory FISH assay for distinguishing between benign and malignant melanocytic neoplasms.
    Gerami P; Li G; Pouryazdanparast P; Blondin B; Beilfuss B; Slenk C; Du J; Guitart J; Jewell S; Pestova K
    Am J Surg Pathol; 2012 Jun; 36(6):808-17. PubMed ID: 22588064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation of melanoma and benign nevi by fluorescence in-situ hybridization.
    Hossain D; Qian J; Adupe J; Drewnowska K; Bostwick DG
    Melanoma Res; 2011 Oct; 21(5):426-30. PubMed ID: 21900793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorescence in situ hybridization as an ancillary method for the distinction of desmoplastic melanomas from sclerosing melanocytic nevi.
    Gerami P; Beilfuss B; Haghighat Z; Fang Y; Jhanwar S; Busam KJ
    J Cutan Pathol; 2011 Apr; 38(4):329-34. PubMed ID: 21323721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deep penetrating nevus-like borderline tumors: A unique subset of ambiguous melanocytic tumors with malignant potential and normal cytogenetics.
    Magro CM; Abraham RM; Guo R; Li S; Wang X; Proper S; Crowson AN; Mihm M
    Eur J Dermatol; 2014; 24(5):594-602. PubMed ID: 25118781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Classifying melanocytic tumors based on DNA copy number changes.
    Bastian BC; Olshen AB; LeBoit PE; Pinkel D
    Am J Pathol; 2003 Nov; 163(5):1765-70. PubMed ID: 14578177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Copy number variations and clinical outcome in atypical spitz tumors.
    Raskin L; Ludgate M; Iyer RK; Ackley TE; Bradford CR; Johnson TM; Fullen DR
    Am J Surg Pathol; 2011 Feb; 35(2):243-52. PubMed ID: 21263245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The correlation of the standard 5 probe FISH assay with melanocytic tumors of uncertain malignant potential.
    Muhlbauer A; Momtahen S; Mihm MC; Wang J; Magro CM
    Ann Diagn Pathol; 2017 Jun; 28():30-36. PubMed ID: 28648937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescence in situ hybridization (FISH) evaluation of chromosomes 6, 7, 9 and 10 throughout human melanocytic tumorigenesis.
    Casorzo L; Luzzi C; Nardacchione A; Picciotto F; Pisacane A; Risio M
    Melanoma Res; 2005 Jun; 15(3):155-60. PubMed ID: 15917696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosomal copy number analysis in melanoma diagnostics.
    North JP; Vemula SS; Bastian BC
    Methods Mol Biol; 2014; 1102():199-226. PubMed ID: 24258981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorescence in situ hybridization for ambiguous melanocytic tumors.
    Gammon B; Gerami P
    Histol Histopathol; 2012 Dec; 27(12):1539-42. PubMed ID: 23059884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular cytogenetic analysis of Spitz nevi shows clear differences to melanoma.
    Bastian BC; Wesselmann U; Pinkel D; Leboit PE
    J Invest Dermatol; 1999 Dec; 113(6):1065-9. PubMed ID: 10594753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.